Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects

Phase 3 Withdrawn Temple University Eli Lilly and Company · collab

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study is to evaluate the effectiveness and safety of atomoxetine in enhancing attention and concentration among childhood survivors of cancer.

Timeline

Start: 2005-11
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Atomoxetine	Other / unclassified	—	—

Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects

Summary

Timeline

Drugs

Indications